People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adimab, LLC | — | Biotechnology | Series A | $13.8M | $499.5M | 2012 |
Michael J. Ross at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael J. Ross on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Errik B. Anderson | 1 | 5 |
| Tillman U. Gerngross | 1 | 5 |
| Robert L. Birnbaum | 1 | 4 |
| Terrance L. McGuire | 1 | 3 |
| William J Maris | 1 | 3 |
| Fran J. Heller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.